-Reuters NEW DELHI: With grain silos spilling over, exports on the rise and an avowed market champion for prime minister, India's threat to trash a global trade deal in the name of food security appears puzzling. But government officials say Prime Minister Narendra Modi is prepared to brazen out global outrage to seize a historic chance to build a rural power base with his defence of farm subsidies and to banish memories...
More »SEARCH RESULT
Total Matching Records found : 69
Conflict of interest in setting norms for pharmaceuticals in WHO -Rema Nagarajan
-The Times of India NEW DELHI: The World Health Organisation's (WHO) work of setting up norms and standards for production of medicines seems to be flawed by a fundamental conflict of interest. At the heart of its standard setting work is an entity the International Conference on Harmonization (ICH) in which majority of the WHO member countries have no voting rights and which is dominated by pharmaceutical industry groups. This glaring...
More »Congress manifesto: right to health is next on agenda -Kundan Pandey et al
-Down to Earth Grand old party of India renews some old promises and makes some new ones, but will Congress live up to its promises if it wins a third term? The Indian National Congress (INC) presented its manifesto for the upcoming Lok Sabha elections on Wedneday. The manifesto committee claimed the 48-page document was prepared after wide consultations by engaging millions of people, grassroots congress workers and every section of the...
More »India must call the US' bluff on patents-Arvind Panagariya
-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...
More »Outside the patent monopolies -Ritu Kamal
-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...
More »
